Dr. Vikas Singh is a distinguished Consultant Urological Oncologist in Indore, specializing in the diagnosis, thorough staging, and sophisticated multimodal treatment of Testicular Cancer (Germ Cell Tumors). Since Testicular Cancer ranks among the most curable solid tumors when managed appropriately, his expertise proves invaluable in customizing therapies—including primary Radical Orchiectomy, specialized Retroperitoneal Lymph Node Dissection (RPLND), and coordinated collaboration with medical oncology for Chemotherapy. He specializes in managing complicated residual disease and conducting post-chemotherapy RPLND (pC-RPLND), which demands advanced surgical proficiency to maximize cure rates while minimizing side effects such as ejaculatory dysfunction.
Attainable in early stages with precise staging and contemporary treatment protocols.
Dedicated emphasis on Urological Oncology, including Testicular Cancer management.
Expertise in Retroperitoneal Lymph Node Dissection (RPLND) following chemotherapy.
This serves as the primary diagnostic instrument to confirm a mass within the testicle. It distinguishes a solid tumor from other benign conditions like epididymitis or hydrocele, determining the necessity for definitive surgery.
Blood analysis for Alpha-fetoprotein (AFP), Beta-human chorionic gonadotropin (β-hCG), and Lactate Dehydrogenase (LDH) is vital for diagnosis, identifying cancer type (Seminoma vs. Non-Seminoma), and monitoring treatment response. These markers are evaluated before and after all interventions.
CT scan of the abdomen, pelvis, and chest is essential to assess spread, particularly to retroperitoneal lymph nodes (the natural drainage pathway for Testicular Cancer). Precise staging using TNM Classification determines whether Active Surveillance, Chemotherapy, or RPLND is subsequently required.
This represents the initial, definitive surgical intervention for Testicular Cancer. It involves removing the entire affected testicle and spermatic cord through a small groin incision (inguinal approach), which is essential for preventing spread and achieving local cure. A testicular prosthesis is frequently offered during surgery or subsequently for cosmetic restoration. The pathological findings from this procedure establish the cancer type and determine the complete treatment strategy. Primary Goal: Definitive primary tumor removal, histological diagnosis, and treatment planning.
For advanced disease, following chemotherapy, residual masses in the retroperitoneum may require surgical removal (pC-RPLND). This is a technically demanding operation, often performed through open approach but occasionally laparoscopically, requiring specialized training. Dr. Singh emphasizes nerve-sparing techniques during RPLND to preserve normal ejaculation and fertility [4], while ensuring complete residual disease clearance to achieve definitive cure. Primary Goal: Removal of residual cancer following chemotherapy, maximizing cure, and protecting future fertility.
Comprehensive discussions on sperm banking and nerve-sparing RPLND to safeguard future family planning.
Following international guidelines for proper sequencing of surgery, chemotherapy, and surveillance.
Safe monitoring protocols for Stage I tumors to prevent unnecessary chemotherapy or surgery.
Discussing and providing testicular prosthetics for natural appearance following orchiectomy.
Schedule a private, confidential consultation with Dr. Singh in Indore.
The overwhelming majority are Germ Cell Tumors (GCTs), primarily classified into two main types: Seminoma and Non-seminoma. Non-seminomas are generally more aggressive and proliferate faster, often necessitating combination therapy, whereas pure Seminomas typically demonstrate high sensitivity to radiation and chemotherapy. Precise pathology from the Orchiectomy establishes the type and directs treatment.
Yes, treatment for Testicular Cancer, including the initial Radical Orchiectomy, necessary Chemotherapy cycles, and complex subsequent surgeries like RPLND, are extensively covered by major health insurance policies, including corporate and government programs (such as Ayushman Bharat). Our team provides assistance in securing smooth and timely pre-authorization for these substantial procedures at Kokilaben Hospital.
The retroperitoneum is the posterior abdominal region where Testicular Cancer most frequently spreads initially. RPLND is a highly specialized surgical procedure to remove these lymph nodes. It’s utilized either for accurate staging (Primary RPLND) or, more typically, to remove residual tumor masses following chemotherapy (pC-RPLND). It represents a critical step for maximizing cure rates and must be performed by an experienced Urological Oncologist to manage potential complications and preserve fertility.
Fertility preservation is a primary consideration. Before initiating treatment (particularly chemotherapy or RPLND), patients are strongly encouraged to undergo sperm banking. Additionally, during the RPLND procedure, Dr. Singh employs nerve-sparing techniques to protect the nerves controlling ejaculation, minimizing the risk of permanent ejaculatory dysfunction.
The leading center for advanced, compassionate urological care and treatment in Indore, Madhya Pradesh.
